Market Snapshot

S&P Futures
Dow Futures
NASDAQ Futures

18.96$-5.08 -21.13 %
At close       04:00 PM    

Stock Snapshot

24.04
Prev. Close
22.02
Open
74.36M
Market Cap
31170.00
Number of Shares
18.60
Day Low
22.47
Day High
18.96
-
P/E Ratio
-
Free Float in %
-0.85
EPS 2021
0.69
Book Value per Share
-
Cash Flow per Share
Cellect Biotechnology Ltd. (APOP)
Cellect Biotechnology Ltd. (APOP) stock rallied over -21.13% intraday to trade at $18.96 share on NASDAQ. The stock opened with a fall of % at $22.02 and touched an intraday high of $22.47, declining 6.53% against the last close of $24.04. The stock went to a low of $18.60 during the session.

Historical Data

DateOpenCloseDaily HighDaily LowVolume
2021-09-24$22.02$21.12$22.47$20.9846,118
2021-09-23$6.00$5.76$6.01$5.73221,566
2021-09-22$6.00$5.85$6.01$5.73180,207
2021-09-21$5.87$5.88$6.01$5.72108,549
2021-09-20$6.25$6.70$6.71$6.21629,944
2021-09-17$6.07$6.34$6.35$5.98314,894
2021-09-16$5.76$6.17$6.29$5.76686,919
2021-09-15$6.22$5.87$6.62$6.02715,258
2021-09-14$6.22$6.47$6.62$6.02851,127
2021-09-13$6.22$6.28$6.34$6.02512,218
2021-09-10$6.38$6.35$6.60$6.25781,998
Cellect Biotechnology Ltd.
23 Hata’as Street
Kfar Saba 44425
Israel

http://www.cellect.co
972 9 974 1444
Employees
14
Sector
Healthcare
Sales or Revenue
-
Industry
Biotechnology
5Y Sales Change
-
Fiscal Year Ends
2020-12-30

Cellect Biotechnology Ltd.
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; and Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state. It also has a collaboration with the Washington University School of Medicine to determine the safety and tolerability of ApoGraft for bone marrow transplantations in the United States. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was founded in 2011 and is headquartered in Kfar Saba, Israel.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam